HealthStream (HSTM) Competitors

Omnicell (NASDAQ:OMCL) and HealthStream (NASDAQ:HSTM) are both small-cap health care technology companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, valuation, earnings, analyst recommendations, profitability, risk and dividends.

Is OMCL or HSTM more profitable?

HealthStream has a net margin of 6.54% compared to Omnicell's net margin of 1.87%. HealthStream's return on equity of 5.36% beat Omnicell's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Omnicell	1.87%	4.60%	2.56%
HealthStream	6.54%	5.36%	3.75%

Do analysts prefer OMCL or HSTM?

Omnicell presently has a consensus price target of $45.33, suggesting a potential upside of 60.36%. HealthStream has a consensus price target of $31.50, suggesting a potential upside of 17.76%. Given Omnicell's higher possible upside, research analysts clearly believe Omnicell is more favorable than HealthStream.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Omnicell	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.57
HealthStream	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.80

Does the media favor OMCL or HSTM?

In the previous week, Omnicell had 5 more articles in the media than HealthStream. MarketBeat recorded 10 mentions for Omnicell and 5 mentions for HealthStream. HealthStream's average media sentiment score of 0.75 beat Omnicell's score of 0.73 indicating that HealthStream is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Omnicell	2 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
HealthStream	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do insiders and institutionals have more ownership in OMCL or HSTM?

97.7% of Omnicell shares are held by institutional investors. Comparatively, 69.6% of HealthStream shares are held by institutional investors. 2.5% of Omnicell shares are held by insiders. Comparatively, 20.5% of HealthStream shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Which has more risk & volatility, OMCL or HSTM?

Omnicell has a beta of 0.76, meaning that its stock price is 24% less volatile than the S&P 500. Comparatively, HealthStream has a beta of 0.42, meaning that its stock price is 58% less volatile than the S&P 500.

Which has better earnings and valuation, OMCL or HSTM?

HealthStream has lower revenue, but higher earnings than Omnicell. HealthStream is trading at a lower price-to-earnings ratio than Omnicell, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Omnicell	$1.11B	1.19	$12.53M	$0.46	61.46
HealthStream	$291.65M	2.80	$20.01M	$0.63	42.46

Summary

HealthStream beats Omnicell on 10 of the 17 factors compared between the two stocks.